Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. | Front Genet | 2022 | 35928454 | PubTator, text mining | PubMed |
| Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. | ESMO Open | 2022 | 35921760 | PubTator, text mining | PubMed |
| Profiles of Microbial Community and Antibiotic Resistome in Wild Tick Species. | mSystems | 2022 | 35913190 | PubTator, text mining | PubMed |
| Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates. | Mol Pharm | 2022 | 35904247 | PubTator, text mining | PubMed |
| Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer. | World J Surg Oncol | 2022 | 35902909 | PubTator, text mining | PubMed |
| GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer. | Clin Med Insights Oncol | 2022 | 35898391 | PubTator, text mining | PubMed |
| The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. | Int J Mol Sci | 2022 | 35897651 | PubTator, text mining | PubMed |
| New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future. | Cancers (Basel) | 2022 | 35892875 | PubTator, text mining | PubMed |
| The Multi-Omics Landscape and Clinical Relevance of the Immunological Signature of Phagocytosis Regulators: Implications for Risk Classification and Frontline Therapies in Skin Cutaneous Melanoma. | Cancers (Basel) | 2022 | 35892841 | PubTator, text mining | PubMed |
| "FLipping" the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors. | Cancers (Basel) | 2022 | 35884458 | PubTator, text mining | PubMed |
| Cell Confluence Modulates TRPV4 Channel Activity in Response to Hypoxia. | Biomolecules | 2022 | 35883510 | PubTator, text mining | PubMed |
| Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration. | Biomolecules | 2022 | 35883472 | PubTator, text mining | PubMed |
| Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies. | Front Oncol | 2022 | 35875135 | PubTator, text mining | PubMed |
| Coactosin-Like Protein in Breast Carcinoma: Friend or Foe? | J Inflamm Res | 2022 | 35873386 | PubTator, text mining | PubMed |
| Medical Assistance in Dying (MAiD) Care Coordination: Navigating Ethics and Access in the Emergence of a New Health Profession. | HEC Forum | 2022 | 35870101 | PubTator, text mining | PubMed |
| Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. | Adv Sci (Weinh) | 2022 | 35869032 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma. | Front Oncol | 2022 | 35860588 | PubTator, text mining | PubMed |
| ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. | Front Immunol | 2022 | 35860243 | PubTator, text mining | PubMed |
| Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study. | Neuropsychiatr Dis Treat | 2022 | 35859802 | PubTator, text mining | PubMed |
| Mechanisms of resistance to immune checkpoint inhibitors. | Cancer Sci | 2022 | 35848888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=31